Literature DB >> 2106872

Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride disks.

H D Jampel1, K W Leong, G R Dunkelburger, H A Quigley.   

Abstract

We performed filtration surgery in glaucomatous monkeys to determine if bioerodible polyanhydride disks that contained 5-fluorouridine (5-FUR) prolonged the success of the operation. First, in vitro studies demonstrated that 5-fluorouridine was released from the disks for at least 16 days in a bioactive form that inhibited fibroblast proliferation. Next, a preliminary series of six eyes suggested that using disks that contained 5-fluorouridine extended the intraocular pressure-lowering effect of filtration surgery. This finding was confirmed in eight additional eyes of four animals in which one eye received a disk with 5-fluorouridine and the other received a disk without the drug. The duration of success of the operation was significantly longer in the eyes that received polyanhydride with 5-fluorouridine (mean +/- SD, 26.0 +/- 9.2 days) than in the controls (8.5 +/- 4.0 days). The histologic findings of the experimental eyes correlated with their prolonged clinical success.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106872     DOI: 10.1001/archopht.1990.01070050128046

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

Review 1.  Glaucoma drainage devices; past, present, and future.

Authors:  K S Lim; B D Allan; A W Lloyd; A Muir; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  193-nm excimer laser sclerostomy using a modified open mask delivery system in rhesus monkeys with experimental glaucoma.

Authors:  B D Allan; P P van Saarloos; R L Cooper; E J Keogh; I J Constable
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

Review 3.  Cross-linked actin networks (CLANs) in glaucoma.

Authors:  Jaclyn Y Bermudez; Michela Montecchi-Palmer; Weiming Mao; Abbot F Clark
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

Review 4.  Biodegradable intraocular therapies for retinal disorders: progress to date.

Authors:  Noriyuki Kuno; Shinobu Fujii
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

Review 5.  Intravitreal devices for the treatment of vitreous inflammation.

Authors:  John B Christoforidis; Susie Chang; Angela Jiang; Jillian Wang; Colleen M Cebulla
Journal:  Mediators Inflamm       Date:  2012-09-05       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.